Abstract
The effect of complement fragments on coronary blood flowin vivo and the contraction of coronary arteriesin vitro was determined. In pentobarbital anesthetized dogs, intraarterial bolus injection of C3a and C5a, zymosan-activated serum and methylcholine in the coronary vascular bed caused transient and dose-dependent increases in coronary blood flow. Similar increases were obtained with 25 μg of C3a (104±13%,n=5) and 0.1 μg of methylcholine (102±4%,n=3). Smaller, increases in blood flow were elicited by 25 μg of C5a (41±18%,n=4) and 0.2 ml, of zymosan-activated serum (48±5%,n=4). None of these responses were associated, with significant changes in left ventricular contractile force measured with a strain gauge, arterial blood pressure, and heart rate. C3a dilated the coronary vascular bed in conscious dogs with an activity equal to or greater than that observed in anesthetized dogs. Isolated canine coronary arteries that were precontracted with serotonin relaxed in response to C3a, whether or not the endothelium was intact. Overall these data suggest that physiologically high doses of anaphylactic complement fragments vasodilate the canine coronary circulation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
J. H. Hill and P. A. Ward,The phlogistic role of C3 leukotactic fragments in myocardial infarcts in rats. J. Exp. Med.133, 885–900 (1971).
R. D. Rossen, J. L. Swain, L. H. Micheall, S. Weakly, E. Gianninil and M. L. Entman,Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle: A possible initiator of an extra myocardial mechanism of ischemic injury. Circ. Res.57, 119–130 (1985).
R. N. Pinckard, R. A. O'Rouk, M. H. Crawford, F. S. Grover, L. M. McManus, J. J. Chidoni and M. S. Olson,Complement activation and mediation of ischemic injury in baboon myocardium. J. Clin. Invest.66, 1050–1056 (1980).
P. R. Maroko, C. Carpenter, M. Chariello, M. C. Fishbein, P. Radvany, J. D. Knostman and S. L. Hale,Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J. Clin. Invest.61, 661–670 (1978).
T. E. Hugli and H. J. Müller-Eberhard,Anaphylatoxins C3a and C5a. InAdvances in immunology. Vol. 26, pp. 1–53 (Eds. F. J. Dixon and H. G. Kunkel). Academic Press, New York 1978.
S. E. Martin, D. E. Chenoweth, R. L. Engler, D. M. Roth and J. C. LonghurstC5a decreases regional coronary blood flow and myocardial function in pigs: Implication for a granulocyte mechanisms. Circ. Res.63, 483–491 (1988).
B. R. Ito, D. M. Roth and R. L. Engler,Thromboxane A 2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs. Circ. Res.66, 596–607 (1990).
G. L. Stahl, E. Amsterdam, J. D. Symons and J. C. Longhurst,Role of thromboxane A 2 in the cardiovascular response to intracoronary C5a. Circ. Res.66, 1103–1111 (1990).
W. A. Schumacher, E. C. Lee and B. R. Lucchesi,Augmentation of streptokinase-induced thrombolysis by heparin and prostacyclin. J. Cardiovas. Pharmacol.7, 739–746 (1985).
S. L. Kunkel, G. L. Manderino, W. Marasco, K. Kaercher, A. A. Hirata and P. A. Ward,Specific enzyme-linked immunosorbent assay (ELISA) for the determination of human C5a antigen. J. Immunolog. Methods62, 41–50 (1983).
K. Pavek, P. J. Piper and G. Smedgård,Anaphylatoxin-induced shock and two patterns of anaphylactic shock; hemodynamics and mediators. Acta Physiol. Scand.105, 393–403 (1979).
W. R. Bennett, D. H. Yawn, P. J. Migliore, J. B. Young, C. M. Pratt, A. E. Raizner, R. Roberts and R. Bolli,Activation of the complement system by recombinant tissue plasminogen activator. J. Am. Coll. Cardiol.10, 627–632 (1987).
T. E. Hugli and F. Marceau,Effects of the C5a anaphylatoxin and its relationship to cyclo-oxygenase metabolites in rabbit vascular strips. Br. J. Pharmacol.84, 725–733 (1985).
U. Hachfeld, R. Levi and M. J. Polley,Cardiac dysfunction caused by purfied C3a anaphylatoxin. Proc. Natl. Acad. Sci.82, 886–890 (1985).
E. Wang, P. S. Kulkarni and K. E. Eakins,Effects of prostaglandins and thromboxane A 2 on the coronary circulation of adult dogs and puppies. Eur. J. Pharmacol.66, 31–41 (1980).
G. J. Grover and W. A. Schumacher,Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogs. J. Cardiovas. Pharmacol.11, 29–35 (1988).
A. L. Hyman, E. W. Spannhake and P. J. Kadowitz,Prostaglandins and the lung. Am. Rev. Respir. Dis.117, 111–136 (1978).
J. Björk, T. E. Hugli and G. Smedegård,Microvascular effects of anaphylatoxin C3a and C5a. J. Immunol.13, 1115–1119 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schumacher, W.A., Fantone, J.C., Kunkel, S.E. et al. The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivo . Agents and Actions 34, 345–349 (1991). https://doi.org/10.1007/BF01988727
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01988727